Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125509551 | 12550955 | 1 | I | 201606 | 20160630 | 20160712 | 20160712 | PER | US-009507513-1607USA000756 | MERCK | 59.08 | YR | F | Y | 0.00000 | 20160712 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125509551 | 12550955 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG/ONCE DAILY | 21995 | 100 | MG | FILM-COATED TABLET | QD | ||||||
125509551 | 12550955 | 2 | C | VICTOZA | LIRAGLUTIDE | 1 | U | 0 | |||||||||||
125509551 | 12550955 | 3 | C | PRINIVIL | LISINOPRIL | 1 | U | 0 | |||||||||||
125509551 | 12550955 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125509551 | 12550955 | 1 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125509551 | 12550955 | Glycosylated haemoglobin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125509551 | 12550955 | 1 | 20160630 | 0 |